496 related articles for article (PubMed ID: 25222764)
1. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
Xie L; Frech-Tamas F; Marrett E; Baser O
Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
[TBL] [Abstract][Full Text] [Related]
2. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: A randomized controlled trial.
Sung J; Ahn KT; Cho BR; Lee SY; Kim BJ; Kim DK; Park JI; Lee WS
Clin Transl Sci; 2021 May; 14(3):1185-1192. PubMed ID: 33503302
[TBL] [Abstract][Full Text] [Related]
3. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
[TBL] [Abstract][Full Text] [Related]
4. Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study.
Kreutz R; Scholze J; Douros A
Curr Vasc Pharmacol; 2018 Jan; 16(2):197-203. PubMed ID: 28828980
[TBL] [Abstract][Full Text] [Related]
5. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
Chrysant SG
Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451
[TBL] [Abstract][Full Text] [Related]
6. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
7. Triple-drug, fixed-dose combinations for the treatment of hypertension: focus on olmesartan/amlodipine/hydrochlorothiazide combination.
Chrysant SG
Drugs Today (Barc); 2011 Mar; 47(3):197-206. PubMed ID: 21494697
[TBL] [Abstract][Full Text] [Related]
8. Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study.
Hussein MA; Chapman RH; Benner JS; Tang SS; Solomon HA; Joyce A; Foody JM
Am J Cardiovasc Drugs; 2010; 10(3):193-202. PubMed ID: 20387911
[TBL] [Abstract][Full Text] [Related]
9. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
Levi M; Pasqua A; Cricelli I; Cricelli C; Piccinni C; Parretti D; Lapi F
J Manag Care Spec Pharm; 2016 Mar; 22(3):255-62. PubMed ID: 27003555
[TBL] [Abstract][Full Text] [Related]
10. Adherence to Triple Single-Pill Combination of Perindopril/Indapamide/Amlodipine: Findings from Real-World Analysis in Italy.
Borghi C; Jayagopal PB; Konradi A; Bortolotto LA; Degli Esposti L; Perrone V; Snyman JR
Adv Ther; 2023 Apr; 40(4):1765-1772. PubMed ID: 36829102
[TBL] [Abstract][Full Text] [Related]
11. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
[TBL] [Abstract][Full Text] [Related]
12. Pill burden in hypertensive patients treated with single-pill combination therapy--an observational study.
Hagendorff A; Freytag S; Müller A; Klebs S
Adv Ther; 2013 Apr; 30(4):406-19. PubMed ID: 23532555
[TBL] [Abstract][Full Text] [Related]
13. Long-term persistence with single-pill, fixed-dose combination therapy versus two pills of amlodipine and perindopril for hypertension: Australian experience.
Simons LA; Chung E; Ortiz M
Curr Med Res Opin; 2017 Oct; 33(10):1783-1787. PubMed ID: 28805468
[TBL] [Abstract][Full Text] [Related]
14. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
Jackson KC; Sheng X; Nelson RE; Keskinaslan A; Brixner DI
Clin Ther; 2008 Aug; 30(8):1558-63. PubMed ID: 18803997
[TBL] [Abstract][Full Text] [Related]
15. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study.
Lauffenburger JC; Landon JE; Fischer MA
J Gen Intern Med; 2017 Jun; 32(6):619-625. PubMed ID: 28050754
[TBL] [Abstract][Full Text] [Related]
16. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation.
Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
Eur J Pharm Sci; 2014 Jan; 51():26-33. PubMed ID: 23999037
[TBL] [Abstract][Full Text] [Related]
17. Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients.
Fogari R; Zoppi A; Mugellini A; Preti P; Perrone T; Maffioli P; Derosa G
Expert Opin Pharmacother; 2012 Apr; 13(5):629-36. PubMed ID: 22372508
[TBL] [Abstract][Full Text] [Related]
18. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
19. [Medication adherence with the fixed combination of ramipril and amlodipine].
Simonyi G; Ferenci T
Orv Hetil; 2014 Nov; 155(47):1882-8. PubMed ID: 25403283
[TBL] [Abstract][Full Text] [Related]
20. Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients With Use of Single-Pill Combinations: Results From the START-Study.
Schmieder RE; Wassmann S; Predel HG; Weisser B; Blettenberg J; Gillessen A; Randerath O; Mevius A; Wilke T; Böhm M
Hypertension; 2023 May; 80(5):1127-1135. PubMed ID: 36987918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
